Basit öğe kaydını göster

EGFR immunoexpression, RAS immunoexpression and their effects on survival in lung adenocarcinoma cases

dc.contributor.authorGundogdu, Ahmet Gokhan
dc.contributor.authorFirat, Pinar
dc.contributor.authorDOĞAN, RIZA
dc.contributor.authorOnder, Sevgen
dc.date.accessioned2021-03-03T15:21:21Z
dc.date.available2021-03-03T15:21:21Z
dc.date.issued2014
dc.identifier.citationGundogdu A. G. , Onder S., Firat P., DOĞAN R., "EGFR immunoexpression, RAS immunoexpression and their effects on survival in lung adenocarcinoma cases", JOURNAL OF THORACIC DISEASE, cilt.6, sa.6, ss.778-784, 2014
dc.identifier.issn2072-1439
dc.identifier.othervv_1032021
dc.identifier.otherav_3e7caf0e-6767-481c-9cbc-5ff9b8d9c73b
dc.identifier.urihttp://hdl.handle.net/20.500.12627/45866
dc.identifier.urihttps://doi.org/10.3978/j.issn.2072-1439.2014.04.35
dc.description.abstractBackground: The impacts of epidermal growth factor receptor (EGFR) immunoexpression and RAS immunoexpression on the survival and prognosis of lung adenocarcinoma patients are debated in the literature.
dc.language.isoeng
dc.subjectTıp
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectGöğüs Hastalıkları ve Allerji
dc.subjectSOLUNUM SİSTEMİ
dc.titleEGFR immunoexpression, RAS immunoexpression and their effects on survival in lung adenocarcinoma cases
dc.typeMakale
dc.relation.journalJOURNAL OF THORACIC DISEASE
dc.contributor.departmentDr. Nafiz Korez Sincan State Hospital , ,
dc.identifier.volume6
dc.identifier.issue6
dc.identifier.startpage778
dc.identifier.endpage784
dc.contributor.firstauthorID215148


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster